Antibiotic resistance and wounded troops Settlements of patent litigation between innovator drug companies and generic drug companies. (S.369 and H.R. 1760)
Comprehensive Reform of Current patent law (H.R. 1260 and S.515)
S. 610 Patent Reform Act of 2009  - changes to drug patent litigation issues Medical Research
Antibiotic Resistance issues
P.L. 111-148 Patient Protection and Affordable Care Act  (PPACA) - funding of PPACA programs and provisions
P.L. 111-152 Health Care and Education Reconciliation Act of 2010 PDUFA Reauthorization - The Prescription Drug User Fee Act is due for reauthorization in 2012 and discussions in anticipation of that reauthorization have begun
H.R. 5712 Health Care Technical Corrections - This bill would repeal a provision of the health care reform bill that would extend debarring to all parts of a corporate family when any part of that corporate family settles an investigation of misconduct with the government
HR 759 Food and Drug Administration Globalization Act of 2009
S. 882 The Drug and Device Accountability Act of 2009
H.R.5740 - To provide for the mandatory recall of adulterated or misbranded drugs
S. 369 Preserve Access to Affordable Generics Act
H.R. 1706 Protecting Consumer Access to Generic Drugs Act
H.R. 573 Fair Prescription Drug Competition Act
S. 501 Fair Prescription Drug Competition Act
H.R. 6331 Generating Antibiotic Incentives Now Act of 2010 
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) - changes to the 340B Drug Discount Program.  
S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals Medicare Coverage Issues
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009
S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) - changes to the 340B Drug Discount Program. P.L. 111-148 Patient Protection and Affordable Care Act (PPACA) - funding of PPACA programs and provisions
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals
S. Amdt. (Baucus) to H.R. 4849 Small Business and Infrastructure Jobs Tax Act of 2010 (340B Provisions)
H.R. 1586 Education Jobs and Medicaid Funding Bill (Average Manufacturer Price - AMP Revisions)
H.R. 4899 Supplemental Appropriations Act, 2010 (Average Manufacturer Price - AMP Revisions and "Pay to Delay" Provision)
H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital and "Pay to Delay" Provisions)
S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions) P.L. 111-148 Patient Protection and Affordable Care Act (PPACA) - funding of PPACA programs and provisions
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital and "Pay to Delay" Provision)
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) - changes to the 340B Drug Discount Program. Medical Research
Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues
Antibiotic Resistance Issues
H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 Methicillin Resistant Staph Aureus (MRSA) Infection Prevention and Patient Protection Act
S. 369 Preserve Access to Affordable Generics Act of 2009
H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions)
DEF - Defense CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA)
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES